Hualan Biological Engineering Inc. (SHE:002007)

China · Delayed Price · Currency is CNY

15.00

+0.06 (0.40%)

Apr 15, 2026, 11:40 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Blood Product	3.39B	3.25B	2.93B	2.68B	2.60B
Blood Product Growth	4.35%	10.91%	9.22%	3.14%	0.25%
Vaccine Product	1.20B	1.12B	2.40B	1.82B	1.82B
Vaccine Product Growth	7.00%	-53.54%	32.30%	-0.38%	-24.63%
Others	12.88M	16.34M	10.89M	20.21M	13.86M
Others Growth	-21.20%	50.09%	-46.11%	45.75%	25.08%
Total	4.60B	4.38B	5.34B	4.52B	4.44B
Total Growth	4.93%	-18.02%	18.26%	1.82%	-11.69%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	4.59B	4.38B	5.33B	4.50B	4.43B
China Growth	4.92%	-17.83%	18.40%	1.58%	-11.82%
Overseas	2.27M	1.73M	14.73M	17.81M	6.92M
Overseas Growth	31.34%	-88.27%	-17.33%	157.52%	-
Total	4.60B	4.38B	5.34B	4.52B	4.44B
Total Growth	4.93%	-18.02%	18.26%	1.82%	-11.69%

Source: S&P Global Market Intelligence.